Learn / GMAB
NASDAQ: GMAB
Genmab A/S (GMAB) stock, explained like you're 5
Genmab A/S trades on the Nasdaq under the ticker GMAB. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 23.1 billion dollars.
- Ticker
- GMAB
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Large cap, about 23.1 billion dollars
Is Genmab A/S a small, medium or large cap company?
Yes. Genmab A/S is a large cap stock. Its market cap, which is the total value of all its shares, is about 23.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Genmab A/S makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves GMAB stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Genmab A/S (GMAB.CO) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- How Investors Are Reacting To Genmab Stock (CPSE:GMAB) Strong Drug Sales And Trial Data (Simply Wall Street)
- J&J reports $2.53B in U.S. DARZALEX sales. Genmab (GMAB) receives royalties worldwide. (Stock Titan)
- Could Genmab (GMAB) Stock Win as Royalty Growth Fuels a New Earnings Cycle? (Yahoo Finance)
- Genmab A/S Stock 12‑Month Price Target Raised to $42, Implies 9% Upside (TradingView)
Follow GMAB in your daily brief
Each trading day at 5 PM ET we post what happened to Genmab A/S and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow GMAB
Questions about Genmab A/S stock
What does Genmab A/S do?
Genmab A/S trades on the Nasdaq under the ticker GMAB. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 23.1 billion dollars.
What is the ticker symbol for Genmab A/S?
Genmab A/S trades under the ticker GMAB on the Nasdaq.
What is Genmab A/S's market cap?
Genmab A/S is a large cap stock with a market cap of about 23.1 billion dollars.
How does Genmab A/S make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves GMAB stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow GMAB stock every day?
Add GMAB to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.